accountBy Lisa Richwine WASHINGTON, Feb 13 (Reuters) - GlaxoSmithKline Plc's (GSK.L Glaxo CEO Andrew Witty said on Friday his company would contribute its own patents for technologies that might aid research into malaria, cholera and more than...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo proposes patent pool for neglected diseases
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account